FDA AdCom votes unanimously in favour of OTC oral contraceptive
Pharmaceutical Technology
MAY 11, 2023
A US Food and Drug Administration (FDA) Advisory Committee (AdCom) has voted unanimously in favour of giving HRA Pharma’s Opill (norgestrel) over-the-counter (OTC) availability. The FDA approved Opill for prescription use in 1973. The therapy only contains the hormone progestin and is taken once daily.
Let's personalize your content